December 17, 2018
WELLESLEY, Mass., Dec. 17, 2018 – As vector-borne diseases such as dengue fever, malaria, West Nile fever, Lyme disease and bubonic plague have become increasingly prevalent in developing and low-income regions of APAC and Africa, the demand for a variety of insect repellent products has surged.
The insect repellent market is expected to reach $4.5 billion in 2023, up from $3.6 billion in 2018, at a compound annual growth rate (CAGR) of 4.5% during the forecast period from 2018 through 2023, according to the report “Insect Repellent: The Global Market to 2023.”
Key players in the market include E.I. du Pont de Nemours and Company, Insect Shield LLC, ExOffcio LLC, Godrej Group (Good Knight), Tender Corporation and S.C. Johnson & Sons Inc.
“The spread of the Zika virus triggered people’s awareness regarding the need for protection from insects, which has increased the global demand for insect repellents,” analyst Mohammed Javed reports. “In addition, many companies collaborated with NGOs and local governments and came together to educate people residing in both urban and rural areas regarding vector-borne diseases.”
Harmful Chemical Effects, Lack of Awareness Top Market Restraints
Although mosquito borne diseases have increased across the globe, there still remains a lack of awareness for those living in rural areas. Many people residing in the Latin America, APAC and Africa regions find themselves using outdated mosquito coils as major distributors fail to produce technologically advanced insect repellent products.
Editors/reporters requesting analyst interviews should contact Eric Surber at firstname.lastname@example.org.
Insect Repellent: The Global Market to 2023( CHM092A )
Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email email@example.com or visit www.bccresearch.com/media to request access to our library of market research.